UMN startup Vascudyne to commercialize biologically engineered tissue

December 3, 2018 — University of Minnesota Technology Commercialization today announced the formal launch of Vascudyne Inc., a startup company based in Stillwater, Minnesota, focused on the development of biologically engineered tissue for medical device and therapeutics applications. The technology offers a regenerative capacity unavailable until now in materials and devices used for medical treatment.

Vascudyne’s technology is based on discoveries by University researcher Robert Tranquillo, PhD, professor in the departments of Biomedical Engineering and Chemical Engineering & Materials Science in the College of Science and Engineering, and researchers in his lab, Zeeshan Syedain, PhD, senior research associate, and Lee Meier, BS, staff scientist and present MD/PhD student.